Elkfork Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $537K | Buy |
5,576
+680
| +14% | +$65.5K | 0.01% | 554 |
|
|
2019
Q2 | $564K | Buy |
4,896
+306
| +7% | +$35.3K | 0.01% | 543 |
|
|
2019
Q1 | $540K | Sell |
4,590
-1,802
| -28% | -$212K | 0.01% | 540 |
|
|
2018
Q4 | $400K | Sell |
6,392
-4,692
| -42% | -$294K | 0.01% | 580 |
|
|
2018
Q3 | $785K | Buy |
11,084
+340
| +3% | +$24.1K | 0.02% | 448 |
|
|
2018
Q2 | $715K | Buy |
10,744
+1,156
| +12% | +$76.9K | 0.02% | 431 |
|
|
2018
Q1 | $627K | Buy |
+9,588
| New | +$627K | 0.02% | 465 |
|